CD8A and melanoma: Krieg et al. demonstrated a significantly increased frequency of antigen specific CD8+ T cells (0.07–3.00%) in 8 of 8 melanoma patients receiving a melanoma antigen vaccine adjuvanted with CpG ODNs compared to eight control patients receiving the vaccine alone (91).